IFI-C · Eucalyptol
Specimen SS-F-CLB-287 // COOL BURN · IFI-C
Eucalyptol I-IV-A
Eucalyptus globulus
Eucalyptus
Tier IEucalyptol
Target Trait
1.2×
fold-change
1,8-cineole accumulation fold-change
Technical Specifications
SKU
SS-F-CLB-287
Genomic Edits
3
GC Content
44.7%
Construct Length
2,450 bp
Promoter System
T7/SP6 cell-free
Expression System
In-vitro T7/SP6 cell-free
Host Strain
Cell-free
Receptor Target
TRPM8
IFI Score
120
Pathway Edits
- TPS-cin (1,8-cineole terpene synthase) codon-optimized overexpression cassette
- GPPS2 (geranyl pyrophosphate synthase 2) upregulation for monoterpene precursor flux
- CYP76F (cytochrome P450 76F subfamily) suppression to reduce competing hydroxylation
- MCT (methylerythritol phosphate cytidylyltransferase) MEP pathway amplification
Key Interventions
1,8-cineole overproduction via TPS-cin/GPPS2 co-upregulation in Eucalyptus globulusTRPM8 weak-agonist/TRPA1-antagonist dual mechanism via eucalyptol elevationCYP76F suppression to redirect flux toward 1,8-cineole rather than competing oxygenates
IFI Subscale Profile
IFI Profile
IFI-S—
IFI-U—
IFI-B—
IFI-K—
IFI-C120
IFI-P—
IFI-A—
IFI-F—
Use Case
Eucalyptus flavor ingredient development, menthol-free cooling formulation, oral care product enhancement, and respiratory wellness product applications.
License
$299 · Tier I License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?